Gossamer Bio GOSS
NASDAQ GOSS
$0.15 0.00 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Property, Plant & Equipment (Net) (2018 - 2026)

Gossamer Bio (GOSS) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Gossamer Bio 49.15 Mn -7.87 Mn - 55,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 55,000.00
Jun 30, 2026 55,000.00
Mar 31, 2026 59,000.00
Mar 31, 2026 59,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00
Sep 30, 2025 70,000.00
Sep 30, 2025 70,000.00
Jun 30, 2025 76,000.00
Jun 30, 2025 76,000.00
Mar 31, 2025 29,000.00
Mar 31, 2025 29,000.00
Dec 31, 2024 10,000.00
Dec 31, 2024 10,000.00
Sep 30, 2024 302,000.00
Sep 30, 2024 302,000.00
Jun 30, 2024 824,000.00
Jun 30, 2024 824,000.00
Mar 31, 2024 1.07 Mn
Mar 31, 2024 1.07 Mn